145 related articles for article (PubMed ID: 19923574)
1. Detection of antibodies against norovirus genogroup GIV in carnivores.
Di Martino B; Marsilio F; Di Profio F; Lorusso E; Friedrich KG; Buonavoglia C; Martella V
Clin Vaccine Immunol; 2010 Jan; 17(1):180-2. PubMed ID: 19923574
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence for norovirus genogroup II, IV and VI in dogs.
Di Martino B; Di Profio F; Melegari I; Sarchese V; Massirio I; Palermo G; Romito G; Lorusso E; Lanave G; Bodnar L; Buonavoglia C; Marsilio F; Green KY; Martella V
Vet Microbiol; 2017 May; 203():68-72. PubMed ID: 28619170
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of norovirus genogroup IV antibodies among humans, Italy, 2010-2011.
Di Martino B; Di Profio F; Ceci C; Di Felice E; Green KY; Bok K; De Grazia S; Giammanco GM; Massirio I; Lorusso E; Buonavoglia C; Marsilio F; Martella V
Emerg Infect Dis; 2014 Nov; 20(11):1828-32. PubMed ID: 25340375
[TBL] [Abstract][Full Text] [Related]
4. Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II.
Almanza H; Cubillos C; Angulo I; Mateos F; Castón JR; van der Poel WH; Vinje J; Bárcena J; Mena I
J Clin Microbiol; 2008 Dec; 46(12):3971-9. PubMed ID: 18842943
[TBL] [Abstract][Full Text] [Related]
5. Expression and antigenicity of virus-like particles of norovirus and their application for detection of noroviruses in stool samples.
Kamata K; Shinozaki K; Okada M; Seto Y; Kobayashi S; Sakae K; Oseto M; Natori K; Shirato-Horikoshi H; Katayama K; Tanaka T; Takeda N; Taniguchi K
J Med Virol; 2005 May; 76(1):129-36. PubMed ID: 15778983
[TBL] [Abstract][Full Text] [Related]
6. A novel feline norovirus in diarrheic cats.
Di Martino B; Di Profio F; Melegari I; Sarchese V; Cafiero MA; Robetto S; Aste G; Lanave G; Marsilio F; Martella V
Infect Genet Evol; 2016 Mar; 38():132-137. PubMed ID: 26739218
[TBL] [Abstract][Full Text] [Related]
7. Discovery and genomic characterization of noroviruses from a gastroenteritis outbreak in domestic cats in the US.
Pinto P; Wang Q; Chen N; Dubovi EJ; Daniels JB; Millward LM; Buonavoglia C; Martella V; Saif LJ
PLoS One; 2012; 7(2):e32739. PubMed ID: 22389721
[TBL] [Abstract][Full Text] [Related]
8. Self-assembly of the recombinant capsid protein of a bovine norovirus (BoNV) into virus-like particles and evaluation of cross-reactivity of BoNV with human noroviruses.
Han MG; Wang Q; Smiley JR; Chang KO; Saif LJ
J Clin Microbiol; 2005 Feb; 43(2):778-85. PubMed ID: 15695679
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of sapovirus in dogs using baculovirus-expressed virus-like particles.
Melegari I; Marsilio F; Di Profio F; Sarchese V; Massirio I; Palombieri A; D'Angelo AR; Lanave G; Diakoudi G; Cavalli A; Martella V; Di Martino B
Virus Res; 2018 Jun; 251():1-5. PubMed ID: 29698676
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel canine norovirus.
Bodnar L; Lorusso E; Di Martino B; Catella C; Lanave G; Elia G; Bányai K; Buonavoglia C; Martella V
Infect Genet Evol; 2017 Aug; 52():75-81. PubMed ID: 28450084
[TBL] [Abstract][Full Text] [Related]
11. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.
Malm M; Tamminen K; Vesikari T; Blazevic V
Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255
[TBL] [Abstract][Full Text] [Related]
12. Identification of a norovirus GII-specific antigenic epitope.
Liu J; Wang Z; Ma J; Ji S; Huo Y
Arch Virol; 2024 May; 169(6):131. PubMed ID: 38819530
[TBL] [Abstract][Full Text] [Related]
13. Norovirus infections and seroprevalence of genotype GII.4-specific antibodies in a Spanish population.
Carmona-Vicente N; Fernández-Jiménez M; Ribes JM; Téllez-Castillo CJ; Khodayar-Pardo P; Rodríguez-Diaz J; Buesa J
J Med Virol; 2015 Apr; 87(4):675-82. PubMed ID: 25655810
[TBL] [Abstract][Full Text] [Related]
14. Seroepidemiology of predominant norovirus strains circulating in Korea by using recombinant virus-like particle antigens.
Son H; Jeong HS; Cho M; Lee J; Lee H; Yoon K; Jeong AY; Jung S; Kim K; Cheon DS
Foodborne Pathog Dis; 2013 May; 10(5):461-6. PubMed ID: 23627928
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a Norovirus-specific monoclonal antibody that exhibits wide spectrum binding activities.
Zheng L; Wang W; Liu J; Chen X; Li S; Wang Q; Huo Y; Qin C; Shen S; Wang M
J Med Virol; 2018 Apr; 90(4):671-676. PubMed ID: 29236287
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cross-reactive norovirus-specific monoclonal antibodies.
Kou B; Crawford SE; Ajami NJ; Czakó R; Neill FH; Tanaka TN; Kitamoto N; Palzkill TG; Estes MK; Atmar RL
Clin Vaccine Immunol; 2015 Feb; 22(2):160-7. PubMed ID: 25428247
[TBL] [Abstract][Full Text] [Related]
17. Genetic heterogeneity and recombination in canine noroviruses.
Martella V; Decaro N; Lorusso E; Radogna A; Moschidou P; Amorisco F; Lucente MS; Desario C; Mari V; Elia G; Banyai K; Carmichael LE; Buonavoglia C
J Virol; 2009 Nov; 83(21):11391-6. PubMed ID: 19710153
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization and pathogenicity of a genogroup GVI feline norovirus.
Takano T; Kusuhara H; Kuroishi A; Takashina M; Doki T; Nishinaka T; Hohdatsu T
Vet Microbiol; 2015 Aug; 178(3-4):201-7. PubMed ID: 26026731
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of canine norovirus in 14 European countries.
Mesquita JR; Delgado I; Costantini V; Heenemann K; Vahlenkamp TW; Vinjé J; Nascimento MS
Clin Vaccine Immunol; 2014 Jun; 21(6):898-900. PubMed ID: 24671552
[TBL] [Abstract][Full Text] [Related]
20. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.
Malm M; Tamminen K; Heinimäki S; Vesikari T; Blazevic V
Vaccine; 2018 Jan; 36(4):484-490. PubMed ID: 29246474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
